Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10064598 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2005 | 7 Pages |
Abstract
Immunological status seems to be a determinant factor in prognosis of cervical SIL, HIV-positive women affected by this lesion, even if low-grade, need more aggressive management than the immunocompetent counterpart. Strict cytologic and colposcopic screening is recommended and CD4+ count and HPV-DNA testing may be useful risk indicators. Excisional procedures are preferred, while ablative treatments or wait and see policy may expose to some risk this type of population with poor compliance to follow-up.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
L. Nappi, C. Carriero, S. Bettocchi, J. Herrero, A. Vimercati, G. Putignano,